Fundraising Fox

Neurodon

Crown Point, US · Founded 2019 · Delaware corporation · 1 known investors

Founders & leadership

Neurodon was founded in 2019 by Russell Dahl and Brunde Broady.

RD
Russell DahlCo-founder
BBBrunde Broady
Brunde BroadyinFounder

Investors · 1

Reported raises · per SEC filings

Form D private placements

$500K disclosed across 1 round · 2019

$500KraisedNov 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Russell DahlExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Neurodon for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$529.1K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2023$286.3K
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2020$2M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2018$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Neurodon?
Neurodon was founded by Russell Dahl, Brunde Broady in 2019.
Who are Neurodon's investors?
Neurodon's investors include Elevate Ventures.
How much funding has Neurodon raised?
Neurodon has disclosed $500K raised across 1 round.
Where is Neurodon headquartered?
Neurodon is headquartered in Crown Point, US.